Ep. 94: Durable Retiree Income — Real Bargains vs Yield Traps

Imagine walking into like an open house and you find this gorgeous mansion, right?
Right. The dream house. Exactly. And the landlord pulls you aside and says,
you know, if you buy this place today, I'll guarantee you a 10% return on your investment
every single year. Oh, wow. Yeah. Yeah. But your first thought shouldn't be, you know, where do I
sign? Yeah. It should probably be, okay, what is structurally wrong with the foundation of this house
that you have to pay me this much just to take it off your hand. I mean, it's a classic red flag,
right? The market is basically flashing this giant warning sign just begging you to look closer.
And that is exactly what we're doing today. Because when you're investing for income,
especially, you know, if you're setting up a retirement portfolio, you want your money working
just as hard as you did. Absolutely. But a massive percentage next to a stock ticker isn't always a
gift. Often it's a yield trap. So our mission for this deep dive is to look at how you actually build
a durable, resilient, retiree income core without stepping on those landmines. Yeah, we have to
avoid the landmines. Right. And we are pulling from some fantastic specialized sources today.
We've got deep dive equity analyses on individual stocks, really great newsletter on the psychology
of monthly dividends, and even a breakdown of some complex covered call funds. And the through line
for all of these sources, I think, is what we're going to call the honest math lens. I like that
honest math. Yeah. Because we are taking that mansion's foundation apart today. We really want to
separate the genuine value plays from the mirages that will, you know, ultimately just leave you stranded.
So let's start with that foundation before anyone starts chasing like a flashy eight or 10% yield on
some random stock. Yeah. The sources suggest you need to pour the concrete. Right. The core. Exactly.
And for most income investors, that concrete is made up of broad dividend ETS. I'm looking at the
notes here. And there seems to be this real tug of war between two specific funds, uh,
SHD and VYM. Why are these the go to foundational blocks? Well, they represent two very different
philosophies for building a core. So let's look at SHD first, which is the Schwab US dividend equity fund.
The sources call this the rising income pick. It's got a current yield of 3.27% and incredibly low
expense ratio, like 0.06%. Wow. That's practically free. Yeah. It really is. And since its inception,
it has averaged a 13.16% annual return. But it's concentrated. You know, it only holds about 100
names, leaning pretty heavily into financials and consumer staples. I mean, 100 names feels a bit narrow
for a financial index fund, doesn't it? Yeah. How does it decide who actually makes the cut? That
is the secret sauce. SHD doesn't just buy any company that pays a dividend. It uses a really
strict quality screen. It actively filters companies based on their return on equity, their cash
colluded debt ratios. And this is key. A mandatory five year to track record of consistently growing
their dividend. Oh, so it's essentially acting like a bouncer at a club, right, making sure only
companies and really good financial health get through the door precisely. Yeah. Now, contrast that
with VYM, which is the Vanguard high dividend yield. Hey, the Van Groen one. This is your set and
forget breath pick. The yield is lower, currently sitting at 2.29%. The historical returns are a bit
softer to around 9.29% since 2006. Okay. So if the yield is lower and the return is lower,
what is the argument for holding VYM instead of SHD? Mass of diversification. VYM holds 618 companies.
Oh wow. 600. Yeah, it's huge. And it has a rock bottom expense ratio of 0.04%. Plus, the overall
payout ratio of the companies in the fund is a very healthy 45.96%. So you're spreading the risk out a lot
more. Exactly. You are sacrificing some of that strict quality screening and some yield in exchange
for holding a massive swath at the market. To put that in perspective, like on a $200,000
position, the yield gap between SHD and VYM is roughly $2,000 a year in cash in your pocket.
Yeah, that's a real trade off. I mean, two grand a year pays for a nice vacation or, you know,
covers a few months of groceries. But reading through these sources, even if you pick your foundational
ECFs, you can't just close your eyes and walk away. The sources highlight something they call the invisible
yield cut. Yes. This is crucial. It really caught my eye. Let's talk about what happened with the Dow
Jones back on June 29th, 2026. It's a brilliant case study in why passive investing isn't truly passive.
On that date, Alphabet, which is the parent company of Google, officially replaced Verizon in the Dow
Jones industrial average. Okay. I see the headline, but connect the dots for me here. Why does a tech
company swapping with a telecom company matter to someone holding a Dow tracking index fund for retirement?
Because your income just took a silent hit. Verizon is a classic old school telecom stock that
pays a hefty dividend, right? Alphabet, on the other hand, pays a dividend now. But the yield is
a microscopic 0.3%. Wait, why is it so low? I mean, Google prints money. They do, but they are pouring
billions of dollars into heavy AI infrastructure capital expenditures. Ah, the AI boom. Yeah, they need
that cash to buy servers, build data centers, secure chips. They aren't in the business of handing cash
back to shareholders right now. They are in an arms race. Okay. Thinking about this, the best way I can
picture it is imagine you hired a property manager for apartment building you won't. Okay. And one day,
the manager quietly evicts a boring, reliable tenant who always pays their rent in full. Yeah. And they
replace them with a flashy tech startup. Right. And the startup says, hey, we're going to be worth a
fortune one day. Maybe you'll get some equity. But they pay absolutely zero rent today. You just lost
your cash low and you didn't even authorize the trade. That is exactly the dynamic, the whole
personality of the index shifts. Now, it's worth noting the Dow still has income stalwarts,
keeping it afloat. Like who? Companies like Cisco yielding around 1.4 to 1.5%, Coca-Cola at 2.56%,
Amgen at 2.71%. But the overall cash being generated by the index naturally shrinks when you swap
a Verizon for an alphabet. And this creates a domino effect. If the yields on these broad index funds
are shrinking, people looking at their monthly bills start to feel the squeeze. Yeah. They need to
make up the difference. Exactly. So what happens? They venture out of the safety of ETFs and start
chasing individual high yielding stocks, which leads us directly into the minefield when investors get
desperate for cash flow. They tend to look at the yield percentage and just totally ignore the actual
business fundamentals. Right. So let's apply our honest math lens to one of the biggest names in
the source material, which is Pfizer, ticker, PFE, a huge name, right, creating around $24.37,
and it boasts a massive 7.27% yield. That's a dollar and 72 cents a year in dividends. To a lot of
people, you know, a 7% payout from a household healthcare giant feels like a total slam dunk. But
the honest math tells a much more complicated story. First, let's just clear up some history here.
Pfizer is not a dividend aristocrat. Oh, really? I assume they were. A lot of people do, but they
actually slashed their dividend back in 2009 to finance the YF acquisition. So management has shown
they are willing to cut if necessary. Good to know. Second, their recent massive revenue driver,
which is the COVID franchise, is falling off a cliff. In the first quarter of 2026,
come here in a naughty vaccine sales were down 59% and packs low bid fell 63%. Sure, but it's
a massive pharmaceutical company. They have other drugs, right? I mean, the source knows products
like patch ever up 39%, Vindicull is up 8%. They are still making money. So how do we actually know
if the dividend is safe? We look at the payout ratio. If you look at Pfizer's adjusted earnings payout
ratio, it sits at 53%. Okay, paying out 53% of their earnings to shareholders. That sounds
perfectly fine. On paper, yeah, it looks incredibly healthy. But earnings are just an accounting
metric. They include all sorts of non cash adjustments. You cannot pay a cash dividend with theoretical
accounting numbers. Right. You need actual cash. Exactly. You have to look at the free cash flow
payout ratio. And for Pfizer, that number is an alarming 108%. Wait, pause for a second. Break
down the difference between earnings and free cash flow for me. Yeah, let's use the actual numbers
from the analysis. Pfizer's projected 2025 operating cash flow. So money actually coming in from their
business is 11.71 billion dollars. Okay, 11.7 billion. But they have to maintain their business,
which means capital expenditures of 2.63 billion. When you subtract the capital expenditures from the
operating cash, you get the free cash flow, which is 9.08 billion dollars. Okay, I think I get
it. It's like looking at your pay stuff. Your earnings might be your gross salary like the $80,000
your employer says you make, right? But your free cash flow is the hard cash actually left in your
checking account at the end of the month after you've paid the mortgage and the utility bills.
That is a perfect translation. So Pfizer has 9.08 billion dollars in their corporate checking account.
But the total dividends they paid out, 9.7 billion dollars. Wow, wow. So they are paying out more
cash than the businesses actually generating. Where is that extra money coming from? They have to be
dipping into savings or taking on debt just to pay the shareholders. And debt is the real pressure
point here. The analysis points out their net debt to EBITDA ratio is sitting at 3.26X, largely from
the debt they took on to acquire Seagun. Let me stop you again. Net debt to EBITDA. I know debt is
what you owe, but what is EBITDA? EBITDA stands for earnings before interest, taxes, depreciation and
amortization. Simply put, it's a measure of a company's raw operating profit before the accountants
get in there and start applying tax deductions and non-cash expenses. Okay. So when we say the ratio
is 3.26X, it means their total debt is more than three times their raw annual operating profit.
That feels really heavy for a company paying out more cash than it actually makes.
It is heavy. The saving grace is that management knows this. They have a $7.2 billion cost-saving
target for 2027 to try and write the ship. And interestingly, insiders are buying. Oh, really?
Yeah. In April 2026, the CEO and 11 directors bought stock heavily with their own money.
I mean, you generally don't buy your own company's stock if you know a massive dividend cut is
happening next week. Yeah. So what's the verdict on Pfizer then? The analysts conclude
the dividend is safe for now, but it is dangerous if that free cash flow coverage stays below 1.0X
for another year. It's the definition of a stock you have to actively monitor, not just, you know,
throw in a drawer and forget about. Okay. So a 7% yield wrapped in a debt problem is a potential trap.
But that makes me wonder, what if we look at a completely different scenario? What if we find a
company with a pristine balance sheet? Zero debt issues. But the stock price itself just fell off a cliff.
Interesting. Because mathematically, if a stock price crashes and the dividend stays the same,
the yield shoots up, right? You are describing the contrarian value play. And our sources highlight
Accenture for this exact scenario. Ticker, ACN. Yeah. Accenture dropped 59% from its 52-week high,
falling from nearly $300 a share down to about $123. Because of that massive price drop,
the yield spiked to 5.18%. And unlike Pfizer, the honest math on their cash flow looks bulletproof.
The payout ratio is just 38% of earnings. So what gives? Why did a premier global consulting firm
lose more than half of its value? Artificial intelligence. Of course. Yeah. The market is
terrified that AI is going to fundamentally automate away the core of Accenture's business model,
which is billing for human consulting hours. The fear is like, why would a client pay a team of
junior consultants for three months of research when an enterprise AI model can generate the exact
same insights in three seconds? Right. And I see in the notes it wasn't just Accenture. The whole
sector got hammered. CTSH dropped over 55%, EPM tank 64%. But I have to push back here. Go for it.
If a company's core product human hours is facing obsolescence, is a 5% yield really worth the risk?
Aren't you just trying to catch a falling knife in a dying industry? That is the multi-billion dollar
question the analysts are debating right now. Accenture isn't a bizarrely unique position
because they actually sell AI implementation to other large corporations, which is a massive
tailwind for their business. Right. They set up the AI for other people. Exactly. But internally,
their own revenue model relies on the very human labor that AI threatens to replace.
It's a massive headwind. We've already seen their revenue growth guidance slip to just three to
four percent. So as an income investor, how do you handle a situation like that? Do you take the
5% yield or just run away? You have to frame it honestly, right? It is a bit. It is not a sure thing.
If you believe the market is overreacting, that human consultants will just use AI to do more complex
work than you buy. You collect your 5% yield and you get paid to wait for the stock price to recover.
But if AI truly compresses their billable hours permanently, it becomes a value trap. The consensus
advice. Size it like a bet. Don't make it a core holding like SHD or VYM. Keep it small enough
that if the thesis breaks, it doesn't sink your retirement. Honestly, parsing through Pfizer's free
cash flow and sweating over Accenture's existential AI crisis sounds completely exhausting. It is a lot
of work. Right. Retirement investing is supposed to be peaceful. And that brings us to an interesting
sub stack in our source stack called the dividend prints. They argue that we need to look at the
emotional tax investing. It is a very real phenomenon. Most individual stocks in ETS paid dividends
quarterly. That means you were waiting 90 days for your cash. Yeah, a long time. And during those 90 days,
you are watching the stock market fluctuate wildly. You are reading doom and gloom headlines and second
guessing your strategy. The sub stack's thesis is that shifting to monthly distribution ETFs creates a
calmer investor. When you get paid every 30 days, you are much less likely to make an emotional
panic-driven decision. Reading through this, it almost feels like paying for a heavy-duty
suspension on a truck. You are actively choosing to trade top speed like your maximum total return
so that you don't spill your coffee every time the market hits a pothole. That's a great way to look
at it. Because all three of the monthly ETS we're about to discuss actually underperform the broader
S&P 500 over the long run. Yes, that is the cost of the suspension. So let's look at the options
they lay out. First is DGRW, the wisdom tree US quality dividend growth fund. This one yields 2.0,
3% with a 0.28% expense ratio. It's built for the growth-minded investor. It holds almost 200 names,
including tech heavyweights like Nvidia, Apple, and Microsoft. And it proved its worth as a shock
absorber in 2022. The source notes that while the S&P 500 dropped over 24% that year,
DGRW only fell 15.61%. Exactly. Now, if you want heavier income, you look at SPHD. That's the
Invesco S&P 500 high dividend low volatility EPF. This one yields much higher between 4.56 and 4.95%.
But it is entirely defensive. It's packed with real estate, consumer staples, and energy.
Think Verizon, Altria, and Pfizer. And for the investor who truly loses sleep over the stock market,
there is EscaloV, the Invesco S&P 500 low volatility fund, yields 2.27% holding the 103 least
volatile names in the index. And there's a killer stat in the notes about this one. Yeah, the downcapture
ratio. Right. Historically, it only captures 58% of the markets downside. But to return to
your truck's suspension analogy, there is always a catch. By heavily capping your downside and
smoothing out your income to monthly payments, you also cap your upside during a roaring bull market.
You have to be psychologically comfortable trailing the market when everyone else is making money,
in exchange for not panicking when everything crashes. That makes total sense. Yeah.
But let's say you've done all this right, you built your ETF foundation, you avoided the Pfizer yield
traps, you signed your Accenture bets properly, you smoothed out the ride with monthly payers.
But you look at your overall portfolio yield and it's still just too low to pay your bills. Yeah,
what then? Right. Where do you go when you literally just need more cash today?
You have to look into the satellite space, specifically highly complex high yield option strategies.
We have a breakdown here from a YouTube analyst looking at two ETFs that use the Russell 2000 index
to generate massive yields. Okay, just to set the table, the Russell 2000 is the small cap section
of the US stock market, right? These are smaller, fast moving, sometimes volatile companies,
not your massive mega caps. Correct. And both of these ETFs, IWMI from NIOs and ITWO from
ProShares, take that volatile small cap index and pair it with a covered call option strategy to
generate monthly income. Okay, before we throw numbers around, remind me and the listener,
how a covered call actually works in plain English. Okay, let's say you own a house worth $100,000.
You sign a contract with me that says, I will pay you $1,000 in cash today. But in exchange,
if the house's value jumps to 120,000 next month, I get to buy it from you for 110. Okay, so I get
guaranteed cash in my pocket today. Yeah. But I basically cap how much profit I can make tomorrow.
Exactly. Cash today, limited upside tomorrow. So how do these two funds actually apply that?
They do it very differently. So IWMI from NIOs is the income first approach. It boasts a staggering
13.4 zero percent yield. 13.4. Wow. Yeah, it generated $7.10 per share in distributions over 12
months. The managers are actively buying and selling options on the index. But 13.4% is huge.
What's the catch under the hood? It's an active strategy, which means it costs more
a 0.68% expense ratio. But it uses a very specific tax structure called Section 1256.
Section 1256. Why does a retiree care about that specific tax code? Because it is incredibly
tax-efficient. Under Section 1256, 60% of the gains generated by those options are taxed as long-term
capital gains and 40% are tax short-term. Oh, that's a big deal. It is. For a retiree generating
high income, paying long-term rates on 60% of that money instead of ordinary income tax saves
a fortune. And even with capping the upside, IWI delivered a 17.32% total return a year-to-date.
That sounds fantastic. Until you look at the competitor, which is ITWO from Pro Shares.
This one is the growth first approach. The yield is much lower,
7.26% or about $3.33 over the year. Why is it so much lower? Because the strategy is entirely different.
ITWO uses what's called a SWAP-based daily-covered-call strategy. It's often referred to as a one DTE
or one-date expiration strategy. So instead of writing options that lock them in for a whole month,
they refresh their options position every single trading day. Hold on, SWAP-based daily-covered
call that sounds like a Wall Street science experiment. What is a SWAP and why are they doing it daily?
A SWAP is basically a contract with a major investment bank. Pro Shares pays a bank to execute
this complex daily option strategy for them. And by resetting the cap on their upside every
single day, they are able to capture a lot more of the underlying small cap markets actual growth,
rather than getting locked into a bad price for an entire month.
Okay, so they sacrifice half the yield to capture more growth. Does it actually work?
The number say yes. ITWO hit a 23.66% year-to-date total return,
beating the NEOS fund by about 8% over a one-year period. But there is a hidden risk here,
which is counterparty risk. Counter-tourary risk. Because they are using SWAPs,
they are relying on that investment bank on the other side of the trade to fulfill the contract.
If that bank suddenly goes under, the fund has a massive problem. Wow, it is a massive contrast.
It is a pure, honest, math trade-off. I mean, do you need maximum cash in hand today to pay your
electric bill? Then IWMI's 13.4% yield and tax efficiency is incredibly tempting.
But if your bills are covered and you want to grow the total plot for tomorrow, ITWO is the clear
winner. You really have to know what you are buying. And that is the ultimate takeaway from all
of these sources. Building a durable income core is entirely an exercise in knowing your trade-offs.
Yeah, let's just recap the journey here. You start by building broad safety,
deciding if you prefer the strict quality screening of SHD, or the massive 600-company
breadth of VYM. Then you have to put on the hard hat and do the honest map on individual stocks.
You look at a Pfizer and realize a 53% earnings payout is great, but a 108% free cash flow payout
is a glaring red flag. You also have to assess risk realistically. When you see Accenture down 59%,
you don't just blindly buy the 5% yield. You acknowledge the AI threat and you size the position
like a bet, not a guarantee. And finally, you have to know what upside you're sacrificing.
Whether that's trading maximum return for the psychological sanity of monthly payers like DGRW,
or picking your flavor of complex satellite yield with IWMI versus ITWO.
You know, if we pull all the way back and look at the big picture here, it raises a really
provocative question for anyone managing their own money. What's that?
We've spent a lot of time analyzing current yields and cash flows. But look at the blistering pace
of technological change we just discussed. AI is threatening Accenture's entire human-based
business model. Alphabet's massive AI capital expenditures just completely altered the
income profile of the Dow Jones index. It feels like the ground is shifting faster than it used to.
It is. Which makes you wonder, does the old school idea of a set and forget dividend stock
even exist anymore? Wow, that's a scary thought. In a world where a technology can rewrite
an industry's economics in two years, will the retiree of the future have to act much more
like an active portfolio manager just to survive? The days of buying a blue chip stock,
putting the certificate in a safe deposit box and living off the dividends for 30 years,
well, they might be officially over. That is a sobering thought, but an essential one to chew on
as you look at your own portfolio. Because as we said at the start, when you were cruising through
retirement looking for yield, that bright, flashing 10% sign might look like an oasis.
But if you aren't doing the honest math, you might just be driving straight toward a mirage.
Keep your eyes on the actual cash flow.